KalVista Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY	FY	FY	FY	FY
Period Ending	Sep '25 Sep 30, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Cash & Equivalents	243.5	131.62	31.79	56.24	30.73	50.59
Short-Term Investments	65.66	89	178.61	93.14	135.47	198.34
Cash & Short-Term Investments	309.16	220.62	210.4	149.38	166.2	248.93
Cash Growth	127.70%	4.86%	40.85%	-10.12%	-33.23%	267.62%
Accounts Receivable	5.78	-	-	-	-	-
Other Receivables	1.34	1.38	8.44	16.57	14.1	10.42
Total Trade Receivables	7.12	1.38	8.44	16.57	14.1	10.42
Inventory	0.46	-	-	-	-	-
Other Current Assets	8.49	19.69	6.85	6.38	13.35	4.92
Total Current Assets	325.23	241.69	225.69	172.33	193.65	264.26
Net Property, Plant & Equipment	12.29	7.53	9.15	10.77	10.04	7.55
Other Long-Term Assets	2.42	1.55	0.57	0.11	0.19	0.2
Total Assets	339.93	250.77	235.4	183.2	203.88	272.01
Accounts Payable	8.07	4.88	9.11	4.82	3.64	1.98
Accrued Expenses	20.77	27.31	12.4	9.13	6.96	6.93
Current Portion of Leases	1.43	1.98	1.3	1.09	0.98	0.86
Unearned Revenue	11.51	11	-	-	-	-
Other Current Liabilities	3.29	-	-	-	-	-
Total Current Liabilities	45.07	45.17	22.81	15.03	11.58	9.77
Long-Term Debt	139.03	-	-	-	-	-
Long-Term Leases	9.13	4.33	6.02	7.15	7.21	5.05
Other Long-Term Liabilities	129.71	105.88	-	-	-	-
Total Long-Term Liabilities	277.86	110.21	6.02	7.15	7.21	5.05
Total Liabilities	322.93	155.38	28.82	22.18	18.79	14.82
Common Stock	0.05	0.05	0.04	0.03	0.03	0.02
Additional Paid-in Capital	762.78	753.73	679.75	507.13	439.1	426.44
Accumulated Other Comprehensive Income	-6.73	-5.21	-3.49	-3.06	-3.86	-1.43
Retained Earnings	-739.1	-653.17	-469.73	-343.08	-250.18	-167.84
Shareholders' Equity	17	95.39	206.58	161.03	185.09	257.19
Total Liabilities & Equity	339.93	250.77	235.4	183.2	203.88	272.01
Total Debt	149.59	6.31	7.32	8.23	8.19	5.91
Net Cash (Debt)	159.57	214.31	203.08	141.14	158.01	243.02
Net Cash Growth	-25.54%	5.53%	43.89%	-10.68%	-34.98%	267.83%
Net Cash Per Share	-	4.32	5.52	5.06	6.46	12.73
Book Value	17	95.39	206.58	161.03	185.09	257.19
Book Value Per Share	-	1.92	5.62	5.77	7.56	13.47
Tangible Book Value	17	95.39	206.58	161.03	185.09	257.19
Tangible Book Value Per Share	-	1.92	5.62	5.77	7.56	13.47

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q